Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Theratechnologies Inc
T.TH
Alternate Symbol(s):
THTX
Healthcare
Biotechnology
Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs...
in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:TH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Oct 31, 2024 3:47pm
RE:RE:Madrigal today
But ai forgot we're in this for the advancement of science and the greater good of humanity, no not for the money as greedy shareholders.
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Oct 31, 2024 3:44pm
RE:Madrigal today
And we have Dr Greenspoon lining up studies that could fill the National library with his NIH sponsored studies.
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Post by
Trogarzon
on Oct 31, 2024 3:40pm
Madrigal today
Want to see what an approved Nash drug company with Sales beat look like... MDGL... hey we have a P3 Nash program ready to go stay tuned... lol.
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Oct 31, 2024 3:37pm
RE:RE:RE:RE:Production of Egrifta is of major material news.
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Oct 31, 2024 11:38am
RE:RE:RE:Production of Egrifta is of major material news.
Frustrating as ever. Slowly coming down until they either completely implode or deliver an onco rabbit.
(56)
•••
Mannequin
X
View Profile
View Bullboard History
Comment by
Mannequin
on Oct 30, 2024 11:27am
RE:RE:Production of Egrifta is of major material news.
Yes, this is obviously material. Good or bad they need to disclose.
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Oct 30, 2024 9:48am
RE:Production of Egrifta is of major material news.
Probably... they can't even share a basic information about if yes or no a batch of Egrifta was made on Oct 21. I think it's material and borderline withholding information from
...more
(22)
•••
Joemare
X
View Profile
View Bullboard History
Post by
Joemare
on Oct 30, 2024 9:02am
Production of Egrifta is of major material news.
So, what is happening? My guess - our super top executives that have managed to tank this company in no time, has again failed. Any bets?
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Post by
Trogarzon
on Oct 28, 2024 8:03am
No news
Whatever happened on Oct. 21 production window of Egrifta is a material event one way or the other I would think. But no information from the company. I mean it's pretty binary, the
...more
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Oct 25, 2024 10:22am
RE:Anyone at Jubilant
Like always keeping the suspense alive. Anyone else lost some sleep since December 2022.
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Post by
Trogarzon
on Oct 24, 2024 8:04pm
Anyone at Jubilant
Anyone know if Jubilant made an Egrifta batch on October 21...
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Post by
Trogarzon
on Oct 23, 2024 7:06am
October 21st
Wonder if they confirm the new batch of Egrifta was made on the 21st. It would be advisable to do so asap. Also the subsequent filing and probable timeline for fda public servants to do their
...more
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Post by
Trogarzon
on Oct 22, 2024 8:15pm
The Research capital upgrade details
https://www.cantechletter.com/2024/10/thtx-upgraded-at-research-capital/amp/ Starts by stating that the Egrifta shortage is in the rear view mirror, then states that it's not fixed yet, then
...more
(54)
•••
PWIB123
X
View Profile
View Bullboard History
Comment by
PWIB123
on Oct 21, 2024 10:52am
RE:RE:Research capital
Appreciate you sharing this. Every little positive step forward is critical at this juncture.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden